Keloid Scars: A randomised clinical and laboratory based study on the treatment and differentiation factors of the local disease - Keloid scars: Pathophysiology and treatment

QUEEN MARY UNIVERSITY OF LONDO0 个研究点目标入组 100 人开始时间: 2011年10月21日最近更新: 2020年9月21日

试验速览

暂无简介。

•Adult (>18 years old). Keloid scarring present. Able to understand and give informed consent. Patients giving informed consent to donate keloidal or non-affected skin when that is redundant after a procedure (i.e. BBR, Abdominoplasty). Patients with a strong familial pedigree of keloid scar formation.
•Are the trial subjects under 18? no
•Number of subjects for this age range: 0
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range 0
•F.1.3 Elderly (>=65 years) yes
•F.1.3.1 Number of subjects for this age range 0

•1. Open wound at or proximity of the lesion 2. Infected lesion 3. Pregnant or planning pregnancy in the near future 4. Lactating (Breast Feeding) 5. Abnormal renal or liver function tests 6. Atrophic scars 7. Patient under 18yrs of age 8. Immunocompromissed OR immunosuppressed

发起方

QUEEN MARY UNIVERSITY OF LONDO